Dr. Ikuyo Yamaguchi, MD

Dr. Yamaguchi practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Yamaguchi's NPI, 1700995073, was assigned on August 30, 2006. Dr. Yamaguchi graduated from Other in 1987. Dr. Yamaguchi holds Texas license P8827.

Dr. Yamaguchi's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Yamaguchi's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Yamaguchi is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Yamaguchi to 1 more hospital, 3 medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yamaguchi practices, 5 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Yamaguchi's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Yamaguchi is board certified in pediatric nephrology by the American Board of Pediatrics. Dmand AI has Dr. Yamaguchi's licenses on file in 4 states: Texas, Oklahoma, Washington and Virginia.

CMS data shows 38 Medicare services from Dr. Yamaguchi across 1 procedure code in 2019, all of them office visits, for 11 Medicare patients. Medicare paid $2,301 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 11 Medicare patients who saw Dr. Yamaguchi in 2024. The largest group is under 65, with 11 patients. Their average risk score is 4.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yamaguchi's median patient age at 14, with 40% women.

In 2024, Dr. Yamaguchi wrote 104 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $454 in total drug cost. In 2023, CMS named 69 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Yamaguchi for performance year 2024, reported as part of a group. Dr. Yamaguchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Yamaguchi, published from 2007 to 2025. 2011 was the busiest year, with 4. The most frequent topics are Fibrosis, Hypertension and Ureteral Obstruction. Dr. Yamaguchi has published most often in Curr Hypertens Rep. Dr. Yamaguchi's most frequent co-authors are Allison A. Eddy, Daryl M. Okamura, MD and Bruce Allen Barshop, MD, PhD.

CMS Open Payments shows 12 general payments to Dr. Yamaguchi from 7 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $91.

Dr. Yamaguchi graduated from Other in 1987.

Dr. Yamaguchi is in network with 15 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.